AIDS-related lymphoma

Blood Reviews

Volumn 13, Issue 3, 1999, Pages 147-150

  Tulpule, A ^a   Levine, A ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; ASPARAGINASE; BLEOMYCIN; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; FOLINIC ACID; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IFOSFAMIDE; METHOTREXATE; PREDNISONE; VINCRISTINE; VINDESINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CANCER GRADING; CENTRAL NERVOUS SYSTEM METASTASIS; CLINICAL FEATURE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRATHECAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; NONHODGKIN LYMPHOMA; OPPORTUNISTIC INFECTION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROGNOSIS; SHORT SURVEY;

EID: 0032862008     PISSN: 0268960X     EISSN: None     Source Type: Journal    
DOI: 10.1054/blre.1999.0112     Document Type: Short Survey

References (31)

1. Pluda J. M., Yarchoan R., Jaffe E. S. Development of lymphoma in a cohort of patients with severe human immunodeficiency virus (HIV) infection on long term antiretroviral therapy. Ann Intern Med. 113:1990;276-282.
2. Jacobson L. P. Impact of highly active antiretroviral therapy on the incidence of malignancies among HIV-infected individuals. J Acquir Immune Defic Syndr Hum Retrovirol. 17(4):1998;S5, A39.
3. Buchbinder S. P., Vittinghoff E., Colfax G., Holmberg S. Declines in AIDS incidence associated with highly active anti-retroviral therapy (HAART) are not reflected in KS and lymphoma incidence. J Acquir Immune Defic Syndr Hum Retrovirol. 17(4):1998;S7, A39.
4. Massod R., Zhang Y., Bond M. W. Interleukin 10 is an autocrine growth factor for AIDS-related B-cell lymphoma. Blood. 85:1995;3423-3430.
5. Liebowitz D. Epstein-Barr virus and a cellular signaling pathway in lymphomas from immunosuppressed patients. N Engl J Med. 338:1998;1413-1421.
6. Gaidino G., Lo Coco F., Ye B. H. Rearrangements of the bcl-6 gene in acquired immunodeficiency syndrome-associated non-Hodgkin's Lymphoma; associated with diffuse large cell subtype. Blood. 84:1994;397-402.
7. Levine A. M., Meyer P. R., Begandy M. K. Development of B-cell lymphoma in homosexual men: clinical and immunologic findings. Ann Intern Med. 100:1984;7-13.
8. Levine A. M., Gill P. S., Meyer P. R. Retrovirus and malignant lymphoma in homosexual men. JAMA. 254:1985;1921-1925.
9. Knowles D. M., Chamulak G. A., Subar M. Lymphoid neoplasia associated with the acquired immunodeficiency syndrome (AIDS): the New York University experience. Ann Intern Med. 108:1988;744-753.
10. Kaplan L. D., Abrams D. I., Feigal E. AIDS-associated non-Hodgkin's lymphoma in San Francisco. JAMA. 261:1989;719-724.
11. Lowenthal D. A., Straus D. J., Campbell S. W. AIDS-related lymphoid neoplasia: the Memorial Hospital Experience. Cancer. 61:1988;2325-2337.
12. Ziegler J. L., Beckstead J. A., Volberding P. A. Non-Hodgkin's lymphoma in 90 homosexual men: relationship to generalized lymphadenopathy and acquired immunodeficiency syndrome (AIDS). N Engl J Med. 311:1984;565-570.
13. Lukes R. J., Parker J. W., Taylor C. R. Immunologic approach to non-Hodgkin's lymphomas and related leukemias. Analysis of the results of multiparameter studies of 425 cases. Semin Hematol. 15:1978;322-351.
14. Cancer. 49:1982;2112-2135.
15. Levine A. M. Reactive and neoplastic lymphoproliferative disorders and other miscellaneous cancers associated with HIV infection. DeVita V. T. Jr, Hellman S., Rosenberg S. A. AIDS: etiology, diagnosis, treatment and prevention. 1982;263-275 JP Lippincott, Philadelphia.
16. Chadburn A., Cesarman E., Jagirdar J. CD30 (Ki-1) positive anaplastic large cell lymphomas in individuals infected with the human immunodeficiency virus. Cancer. 72:1993;3078-3090.
17. Levine A. M. HIV-related lymphoma: prognostic factors predictive of survival. Blood. 72:1988;247a.
18. Strauss D. J., Huang J., Testa M. A. Prognostic factors in the treatment of HIV-associated non-Hodgkin's lymphoma (HANHL): analysis of ACTG 142 (low dose vs. standard dose m-BACOD + GM-CSF). J Acquir Immune Defic Syndr Hum Retrovirol. 14(4):1997;A38.
19. Levine A. M. Human immuno deficiency virus-related lymphoma. Cancer. 68:1991;2446-2472.
20. Gill P. S., Levine A. M., Krailo M. AIDS-related malignant lymphoma: results of prospective treatment trials. J Clin Oncol. 5:1987;1322-1328.
21. Levine A. M., Tulpule A., Espina B. Low dose methotrexate, bleomycin, doxorubicin, cyclophosphamide, vincristine, and dexamethasone with zalcitabine in patients with acquired immunodeficiency syndrome-related lymphoma. Cancer. 78:1996;517-526.
22. Kaplan L. D., Strauss D. J., Testa M. A. Low dose compared with standard-dose m-BACOD chemotherapy for non-Hodgkin's lymphoma associayed with human immunodeficiency virus infection. N Engl J Med. 336(23):1997;1641-1648.
23. Sporano J. A., Wiernik P. H., Hu X. Pilot trial of infusional cyclophosphamide, doxorubicin, and etoposide plus didanosine and filgrastim in patients with human immunodeficiency virus-associated non-Hodgkin's lymphoma. J Clin Oncol. 14(11):1996;3026-3035.
24. Gisselbrecht C., Oksenhendler E., Tirelli V. Human immunodeficiency virus-related lymphoma treatment with intensive combination chemotherapy. Am J Med. 95:1993;188-196.
25. Gerard L., Oksenhendler E., Lepage E., Gisselbrecht C. Intensive chemotherapy for HIV related non-Hodgkin's lymphoma: long-term follow-up and prognostic factors. Int Conf AIDS. 11(2):1996.
26. Gill P. S., Graham R. A., Boswell W. A comparison of imaging, clinical and pathologic aspects of space occupying lesions within the brain in patients with acquired immunodeficiency syndrome. Am J Physiol Imag. 1:1986;134-141.
27. So Y. T., Beckstead J. H., Davis R. L. Primary central nervous system lymphoma in acquired immune deficiency syndrome: a clinical and pathological study. Ann Neurol. 20:1986;566-572.
28. Garcia F., Lomena A. F., Cruceta A. Predictive value of thallium -201 SPECT in the diagnosis of primary central nervous system lymphoma. (PCNSL) in AIDS patients. Abstract 22291. 12th World AIDS Conference, Geneva, Switzerland, 1998.
29. Cingolani A., Larocca L. M., De Luca A. Phenotypic profile and change in cerebrospinal fluid EBV-DNA burden during therapy as prognostic factors in AIDS-related primary central nervous system lymphoma. Abstract 103. J Acquir Immune Defic Syndr Hum Retrovirol. 17:1998.
30. Formenti S. C., Gill P. S., Lean E. Primary central nervous system lymphoma in AIDS: results of radiation therapy. Cancer. 63:1989;1101-1107.
31. Baumgartner J. E., Rachlin J. R., Beckstead J. H. Primary central nervous system lymphomas: natural history and response to radiation therapy in 55 patients with acquired immunodeficiency syndrome. J Neurosurg. 73:1990;206-211.